|
2025-03-19 |
2025-03-18 |
S
Sale
|
Berkowitz Noah
Chief Medical Officer
Officer
|
8,658
-7.3%
8.59
USD 74,372
|
8,658
-7.3%
|
8.59
|
USD 74,372
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Cacace Angela M
Chief Scientific Officer
Officer
|
1,146
-1.2%
16.55
USD 18,966
|
1,146
-1.2%
|
16.55
|
USD 18,966
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Cacace Angela M
Chief Scientific Officer
Officer
|
3,061
-3.0%
16.75
USD 51,272
|
3,061
-3.0%
|
16.75
|
USD 51,272
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Houston John G
President and CEO
Executive Director
|
5,154
-0.4%
16.55
USD 85,299
|
5,154
-0.4%
|
16.55
|
USD 85,299
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Houston John G
President and CEO
Executive Director
|
26,184
-2.2%
16.75
USD 438,582
|
26,184
-2.2%
|
16.75
|
USD 438,582
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Loomis David K
Chief Accounting Officer
Officer
|
1,214
-6.0%
16.75
USD 20,335
|
1,214
-6.0%
|
16.75
|
USD 20,335
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Taylor Ian
President, R&D
Officer
|
1,664
-1.0%
16.55
USD 27,539
|
1,664
-1.0%
|
16.55
|
USD 27,539
|
|
|
2025-02-25 |
2025-02-24 |
S
Sale
|
Taylor Ian
President, R&D
Officer
|
7,356
-4.4%
16.75
USD 123,213
|
7,356
-4.4%
|
16.75
|
USD 123,213
|
|
|
2024-11-12 |
2024-11-07 |
S
Sale
|
Loomis David K
Chief Accounting Officer
Officer
|
231
-2.8%
27.69
USD 6,396
|
231
-2.8%
|
27.69
|
USD 6,396
|
|
|
2024-02-27 |
2024-02-23 |
S
Sale
|
Peck Ronald
Chief Medical Officer
Officer
|
1,699
-2.5%
47.05
USD 79,938
|
1,699
-2.5%
|
47.05
|
USD 79,938
|
|
|
2024-02-27 |
2024-02-23 |
S
Sale
|
Houston John G
President and CEO
Executive Director
|
5,196
-0.5%
47.05
USD 244,472
|
5,196
-0.5%
|
47.05
|
USD 244,472
|
|
|
2024-02-27 |
2024-02-23 |
S
Sale
|
Cassidy Sean A
Chief Financial Officer
Officer
|
1,702
-0.9%
47.05
USD 80,079
|
1,702
-0.9%
|
47.05
|
USD 80,079
|
|
|
2024-02-27 |
2024-02-23 |
S
Sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
1,701
-1.1%
47.05
USD 80,032
|
1,701
-1.1%
|
47.05
|
USD 80,032
|
|
|
2024-11-12 |
2023-11-08 |
S
Sale
|
Loomis David K
Chief Accounting Officer
Officer
|
229
-2.7%
17.05
USD 3,904
|
229
-2.7%
|
17.05
|
USD 3,904
|
|
|
2023-08-14 |
2023-08-11 |
S
Sale
|
Peck Ronald
Chief Medical Officer
Officer
|
1,324
-4.2%
24.39
USD 32,289
|
1,324
-4.2%
|
24.39
|
USD 32,289
|
|
|
2023-03-03 |
2023-03-01 |
S
Sale
|
Houston John G
President and CEO
Executive Director
|
5,878
-0.6%
29.53
USD 173,577
|
5,878
-0.6%
|
29.53
|
USD 173,577
|
|
|
2023-03-03 |
2023-03-01 |
S
Sale
|
Cassidy Sean A
Chief Financial Officer
Officer
|
1,745
-0.9%
29.53
USD 51,530
|
1,745
-0.9%
|
29.53
|
USD 51,530
|
|
|
2023-03-03 |
2023-03-01 |
S
Sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
1,051
-1.0%
29.53
USD 31,036
|
1,051
-1.0%
|
29.53
|
USD 31,036
|
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
Peck Ronald
Chief Medical Officer
Officer
|
1,258
-13.4%
68.99
USD 86,794
|
1,258
-13.4%
|
68.99
|
USD 86,794
|
|
|
2022-04-18 |
2022-04-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
10,754
-35.0%
67.03
USD 720,888
|
10,754
-35.0%
|
67.03
|
USD 720,888
|
|
|
2022-04-18 |
2022-04-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
7,104
-18.8%
66.07
USD 469,356
|
7,104
-18.8%
|
66.07
|
USD 469,356
|
|
|
2022-04-18 |
2022-04-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
3,102
-7.6%
65.24
USD 202,372
|
3,102
-7.6%
|
65.24
|
USD 202,372
|
|
|
2022-03-15 |
2022-03-11 |
PS
Planned sale
|
Cassidy Sean A
Chief Financial Officer
Officer
|
15,000
-8.5%
70.00
USD 1,050,000
|
15,000
-8.5%
|
70.00
|
USD 1,050,000
|
|
|
2022-03-04 |
2022-03-04 |
S
Sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
869
-1.0%
63.94
USD 55,564
|
869
-1.0%
|
63.94
|
USD 55,564
|
|
|
2022-03-04 |
2022-03-04 |
S
Sale
|
Cassidy Sean A
Chief Financial Officer
Officer
|
1,593
-1.0%
63.94
USD 101,856
|
1,593
-1.0%
|
63.94
|
USD 101,856
|
|
|
2022-03-04 |
2022-03-04 |
S
Sale
|
Houston John G
President and CEO
Executive Director
|
6,024
-0.7%
63.94
USD 385,175
|
6,024
-0.7%
|
63.94
|
USD 385,175
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
100
-0.1%
76.58
USD 7,658
|
100
-0.1%
|
76.58
|
USD 7,658
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
300
-0.4%
75.80
USD 22,740
|
300
-0.4%
|
75.80
|
USD 22,740
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
3,841
-4.6%
74.64
USD 286,692
|
3,841
-4.6%
|
74.64
|
USD 286,692
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
4,126
-4.7%
73.68
USD 304,004
|
4,126
-4.7%
|
73.68
|
USD 304,004
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
5,766
-6.2%
72.55
USD 418,323
|
5,766
-6.2%
|
72.55
|
USD 418,323
|
|
|
2022-02-17 |
2022-02-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
5,867
-5.9%
71.74
USD 420,899
|
5,867
-5.9%
|
71.74
|
USD 420,899
|
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
2,108
-7.8%
67.69
USD 142,696
|
2,108
-7.8%
|
67.69
|
USD 142,696
|
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
5,100
-16.0%
67.28
USD 343,144
|
5,100
-16.0%
|
67.28
|
USD 343,144
|
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
3,833
-10.7%
65.24
USD 250,071
|
3,833
-10.7%
|
65.24
|
USD 250,071
|
|
|
2022-01-19 |
2022-01-14 |
PS
Planned sale
|
Morrison Briggs
Non-Executive Director
|
9,919
-21.7%
64.33
USD 638,109
|
9,919
-21.7%
|
64.33
|
USD 638,109
|
|
|
2022-01-04 |
2021-12-30 |
PS
Planned sale
|
Peck Ronald
Chief Medical Officer
Officer
|
8,629
-61.5%
80.96
USD 698,604
|
8,629
-61.5%
|
80.96
|
USD 698,604
|
|
|
2022-01-04 |
2021-12-30 |
PS
Planned sale
|
Peck Ronald
Chief Medical Officer
Officer
|
11,371
-44.8%
80.35
USD 913,660
|
11,371
-44.8%
|
80.35
|
USD 913,660
|
|
|
2021-12-21 |
2021-12-17 |
PS
Planned sale
|
Cassidy Sean A
Chief Financial Officer
Officer
|
15,000
-8.7%
70.00
USD 1,050,000
|
15,000
-8.7%
|
70.00
|
USD 1,050,000
|
|
|
2021-12-16 |
2021-12-16 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
37,206
-16.7%
68.97
USD 2,566,031
|
37,206
-16.7%
|
68.97
|
USD 2,566,031
|
|
|
2021-12-16 |
2021-12-16 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
48,499
-17.9%
69.66
USD 3,378,387
|
48,499
-17.9%
|
69.66
|
USD 3,378,387
|
|
|
2021-12-16 |
2021-12-15 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
5,695
-2.1%
65.74
USD 374,366
|
5,695
-2.1%
|
65.74
|
USD 374,366
|
|
|
2021-12-16 |
2021-12-15 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
67,549
-19.6%
66.50
USD 4,492,326
|
67,549
-19.6%
|
66.50
|
USD 4,492,326
|
|
|
2021-12-16 |
2021-12-15 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
40,292
-10.5%
67.46
USD 2,718,272
|
40,292
-10.5%
|
67.46
|
USD 2,718,272
|
|
|
2021-12-16 |
2021-12-14 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
700
-0.2%
64.20
USD 44,941
|
700
-0.2%
|
64.20
|
USD 44,941
|
|
|
2021-12-16 |
2021-12-14 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
36,308
-8.6%
65.38
USD 2,373,959
|
36,308
-8.6%
|
65.38
|
USD 2,373,959
|
|
|
2021-12-16 |
2021-12-14 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
119,456
-22.1%
66.01
USD 7,885,099
|
119,456
-22.1%
|
66.01
|
USD 7,885,099
|
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
6,484
-7.6%
84.95
USD 550,845
|
6,484
-7.6%
|
84.95
|
USD 550,845
|
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
6,660
-7.3%
84.14
USD 560,392
|
6,660
-7.3%
|
84.14
|
USD 560,392
|
|
|
2021-11-17 |
2021-11-15 |
PS
Planned sale
|
Taylor Ian
Chief Scientific Officer
Officer
|
6,856
-7.0%
83.07
USD 569,509
|
6,856
-7.0%
|
83.07
|
USD 569,509
|
|
|
2021-11-15 |
2021-11-15 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
3,532
-0.6%
83.90
USD 296,347
|
3,532
-0.6%
|
83.90
|
USD 296,347
|
|
|
2021-11-15 |
2021-11-15 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
17,752
-3.2%
85.07
USD 1,510,122
|
17,752
-3.2%
|
85.07
|
USD 1,510,122
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
12,760
-2.2%
84.02
USD 1,072,100
|
12,760
-2.2%
|
84.02
|
USD 1,072,100
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
9,660
-1.7%
84.31
USD 814,474
|
9,660
-1.7%
|
84.31
|
USD 814,474
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
17,449
-2.9%
85.96
USD 1,499,886
|
17,449
-2.9%
|
85.96
|
USD 1,499,886
|
|
|
2021-11-15 |
2021-11-11 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
36,210
-5.7%
85.92
USD 3,111,333
|
36,210
-5.7%
|
85.92
|
USD 3,111,333
|
|
|
2021-11-15 |
2021-11-11 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
18,007
-2.7%
86.38
USD 1,555,468
|
18,007
-2.7%
|
86.38
|
USD 1,555,468
|
|
|
2021-11-15 |
2021-11-11 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
5,582
-0.8%
87.71
USD 489,591
|
5,582
-0.8%
|
87.71
|
USD 489,591
|
|
|
2021-11-15 |
2021-11-10 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
199
-0.0%
86.59
USD 17,231
|
199
-0.0%
|
86.59
|
USD 17,231
|
|
|
2021-11-15 |
2021-11-10 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
3,956
-0.6%
87.11
USD 344,624
|
3,956
-0.6%
|
87.11
|
USD 344,624
|
|
|
2021-11-15 |
2021-11-10 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
5,853
-0.9%
88.12
USD 515,760
|
5,853
-0.9%
|
88.12
|
USD 515,760
|
|
|
2021-11-15 |
2021-11-10 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
1,498
-0.2%
89.16
USD 133,560
|
1,498
-0.2%
|
89.16
|
USD 133,560
|
|
|
2021-11-15 |
2021-11-10 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
1,852
-0.3%
90.18
USD 167,013
|
1,852
-0.3%
|
90.18
|
USD 167,013
|
|
|
2021-11-09 |
2021-11-09 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
580
-0.1%
91.33
USD 52,969
|
580
-0.1%
|
91.33
|
USD 52,969
|
|
|
2021-11-09 |
2021-11-09 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
27,297
-3.9%
91.85
USD 2,507,093
|
27,297
-3.9%
|
91.85
|
USD 2,507,093
|
|
|
2021-11-09 |
2021-11-09 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
5,131
-0.7%
92.73
USD 475,800
|
5,131
-0.7%
|
92.73
|
USD 475,800
|
|
|
2021-11-09 |
2021-11-08 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
3,688
-0.5%
92.48
USD 341,051
|
3,688
-0.5%
|
92.48
|
USD 341,051
|
|
|
2021-11-09 |
2021-11-08 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
11,130
-1.5%
93.03
USD 1,035,446
|
11,130
-1.5%
|
93.03
|
USD 1,035,446
|
|
|
2021-11-09 |
2021-11-08 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
11,668
-1.6%
94.20
USD 1,099,129
|
11,668
-1.6%
|
94.20
|
USD 1,099,129
|
|
|
2021-11-09 |
2021-11-08 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
54,568
-6.9%
94.93
USD 5,180,255
|
54,568
-6.9%
|
94.93
|
USD 5,180,255
|
|
|
2021-11-09 |
2021-11-05 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
2,747
-0.3%
89.86
USD 246,854
|
2,747
-0.3%
|
89.86
|
USD 246,854
|
|
|
2021-11-09 |
2021-11-05 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
8,676
-1.1%
91.09
USD 790,300
|
8,676
-1.1%
|
91.09
|
USD 790,300
|
|
|
2021-11-09 |
2021-11-05 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
15,327
-1.9%
91.81
USD 1,407,244
|
15,327
-1.9%
|
91.81
|
USD 1,407,244
|
|
|
2021-11-09 |
2021-11-05 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
1,825
-0.2%
93.03
USD 169,785
|
1,825
-0.2%
|
93.03
|
USD 169,785
|
|
|
2021-11-09 |
2021-11-05 |
S
Sale
|
Ratcliffe Liam
Non-Executive Director
|
4,519
-0.5%
94.08
USD 425,136
|
4,519
-0.5%
|
94.08
|
USD 425,136
|
|
